scholarly journals How do patients with exacerbated chronic obstructive pulmonary disease experience care in the intensive care unit?

2013 ◽  
Vol 28 (4) ◽  
pp. 741-748 ◽  
Author(s):  
Henny Torheim ◽  
Marit Kvangarsnes
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Intensive Care Unit ◽  
Intensive Care ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Disease Experience

scholarly journals Moxifloxacin in Chronic Obstructive Pulmonary Disease: Pharmacokinetics and Penetration into Bronchial Secretions in Ward and Intensive Care Unit Patients

2019 ◽  
Vol 63 (3) ◽  
Author(s):  
Maria Sionidou ◽  
Katerina Manika ◽  
Georgia Pitsiou ◽  
Paschalina Kontou ◽  
Kalliopi Chatzika ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Intensive Care Unit ◽  
Intensive Care ◽  
Pulmonary Disease ◽  
Pharmacokinetic Profile ◽  
Pharmacokinetic Parameters ◽  
Chronic Obstructive ◽  
Icu Patients ◽  
Obstructive Pulmonary Disease ◽  
Bronchial Secretions

ABSTRACT This study aimed to evaluate the pharmacokinetic profile of moxifloxacin (MXF) in serum and sputum/bronchial secretions of 22 patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) hospitalized in the ward and intensive care unit (ICU). The data showed that ICU patients had lower concentrations in secretions (P = 0.01). However, no other statistically significant differences were observed in pharmacokinetic parameters and penetration in secretions between ward and ICU patients. MXF showed a favorable pharmacokinetic profile, and the pharmacodynamic targets for common pathogens for AECOPD were achieved.

Sign in / Sign up

Export Citation Format

Share Document